Apolipoprotein E (apoE), a 34-kD glycosylated lipid-binding protein, is expressed as three common isoforms in humans (E2, E3, or E4). Clinical evidence suggests that the apoE genotype (APOE) may be a risk factor for poor outcome after acute central nervous system injury. This was examined further in transgenic mice constructed with the human APOE3 or APOE4 gene under the control of human promoter and tissue expression elements. Presence of human apoE3 and apoE4 pro teins in brains of human APOE homozygous transgenic mice was confirmed by Western blotting. APOE3 (n = 12) and APOE4 (n = 10) mice underwent 60 minutes of middle cere bral artery occlusion. After 24-hour recovery, infarct size was
measured. Infarct volumes (mean ± standard deviation) were smaller in the APOE3 group (cortex: APOE3 = 18 ± 4 mm 3 ; APOE4 = 30 ± II mm 3 , P = 0.04; subcortex: APOE3 = 12 ± 4 mm 3 ; APOE4 = 18 ± 4mm 3 , P = 0.003). Hemiparesis was less severe in APOE3 mice (P = 0.02). These data indicate that human isoform-specific effects of apoE are relevant to acute pathomechanisms of focal ischemic brain damage when exam ined in the mouse. APOE transgenic mice may provide an appropriate model to examine the mechanistic basis for the differential effects of human apoE isoforms in acute central nervous system injury. Key Words: Apolipoprotein E Brain-Ischemia-Mouse, with poor outcome from various forms of acute brain injury, including intracerebral hemorrhage (Alberts et aI., 1995) , closed head injury (Nicoll et aI., 1995; Roses and Saunders, 1995; Seliger et aI., 1997; Sorbi et aI., 1996) , and stroke (Basun et aI., 1996; Slooter et aI., 1997) .
APOE4 also has been associated with worse neuropsy chiatric deficits after cardiopulmonary bypass in humans (Newman et aI, 1995) .
ApoE is secreted locally by macrophages after periph eral nerve injury and by astrocytes and oligodendrocytes after central nervous system insults (Skene and Shooter, 1983; Stoll and Mueller, 1986; Stoll et aI., 1989) . In both gerbils and rats, apoE is expressed in selectively vulner able hippocampal neurons after transient forebrain isch emia (Ali et aI., 1996; Hall et aI., 1995; Horsburgh and Nicoll, 1996a,b; Kida et aI., 1995) . Mice deficient for apoE have worse outcomes from focal ischemic insults than wild-type controls (Laskowitz et aI., 1997 b) . The aforementioned studies have defined a response of apoE to ischemic stress but have not examined the role of isoform specificity. The purpose of this study was to determine whether outcome from transient focal cerebral ischemia is dependent on isoform specificity of the hu man APOE allele in transgenic mice.
MATERIALS AND METHODS
This study was approved by the Duke University Animal Care and Use Committee.
Transgenic mice
The methods for obtaining the APOE3 and APOE4 human transgene constructs have been reported previously (Xu et aI., 1996) . Briefly, cosmid libraries were constructed from Iympho blasts of humans known to be homozygous carriers for APOE3 or APOE4. Fragments containing human regulatory sequences and the coding sequences for human APOE were isolated and microinjected into single-cell embryos from APOE-deficient mice to produce transgenic mice. Animals were bred to homo zygosity. The presence of human and APOE "knockout" genes was confirmed by polymerase chain reaction (Xu et aI., 1996) . Mode of integration and copy numbers of transgenes were analyzed by Southern blotting. Serum cholesterol concen tration was determined to be normalized for both E3 and E4 mice. Presence of the human apoE protein in neurons and glia was confirmed by immunohistochemistry. For the following study, the APOE3-437 and APOE4-8 1 lineages were selected based on determination that both lines carry two copies of the respective transgenes (Xu et aI., 1996) .
Immunoblot detection of apolipoprotein E
Brain homogenates from 8-week old APOE3-437 or as negative controls on brain homogenates derived from APOE-deficient mice (The Jackson Laboratory, Bar Harbor, ME, U.S.A.).
Focal ischemia-reperfusion model
Male APOE3-437 (n = 12) and APOE4-8 1 (n = 10) mice (8-10 weeks of age) were fasted for 12 to 14 hours but were allowed free access to water. Animals then were prepared for middle cerebral artery occlusion using modifications of tech niques described by others (Huang et aI., 1994; Zea Longa et aI., 1989) . With the surgical operator blinded to genetic iden tity, mice were anesthetized with 1.0% to I.S% halothane in SO% oxygenlbalance nitrogen delivered via snout mask and allowed to breathe spontaneously. Via a midline cervical skin incision, the right common carotid artery was identified. The external carotid artery was ligated and transected. The internal carotid artery was dissected distally until the origin of the pterygopalatine artery was visualized. After surgical prepara tion, a IS-minute interval was allowed for physiologic stabili zation. Rectal temperature was monitored continuously and ser voregulated with surface heating/cooling at 37.0°C throughout the procedure.
A 6-0 nylon monofilament was blunted at the tip in a flame and then lightly coated with silicone. The filament was inserted into the proximal external carotid artery stump and advanced �Il mm into the internal carotid artery to occlude the middle cerebral artery. Inspired halothane concentration was reduced to 0.9% at time of filament insertion. After 60 minutes, the filament was removed, and the skin incision was closed with suture. Ten minutes after filament removal, halothane was dis continued and the mice were allowed to awaken. The mice were placed in an oxygen-enriched environment (fraction of inspired oxygen [Fi0 2 ] = SO%) for 1 hour and then returned to their cages.
All animals were evaluated neurologically 24 hours after reperfusion. Each mouse was assigned a score of 0 to 4, where o = no observable neurologic deficit; 1 = failure to extend the left forepaw; 2 = circling to the left; 3 = falling to the left; and 4 = cannot walk spontaneously (Yang and Betz, 1994) . Neu rologic examination was performed by one observer blinded to group assignment.
After neurologic evaluation, animals were anesthetized with halothane and decapitated. The brain was removed and frozen at -20°C. Using a cryotome, 20-J.Lm thick coronal sections were taken at 320-J.Lm intervals over the rostral-caudal extent of the infarct. The sections were dried and stained with hema toxylin and eosin. 
Measurement of physiologic parameters
Because the blood volume required for analytic assays was great enough to cause hypovolemia, a parallel study was per-formed to define the probable physiologic state of mice sub jected to focal ischemia. Both APOE3-437 and APOE4-S1 mice were examined (n = 4 per group). These animals under went a surgical procedure and middle cerebral artery occlusion insult identical to the aforementioned one. In addition, a peri cranial needle thermistor was placed adjacent to the skull, be neath the temporalis. Servoregulation of body temperature was performed via the rectal probe. Therefore, only pericranial tem perature was monitored. A right femoral arterial catheter was placed to monitor blood pressure and withdraw blood. Physi ologic values were measured 10 minutes before and 45 minutes after onset of ischemia. The animals then were killed by an overdose of halothane anesthesia.
Statistical analysis
Infarct volumes and physiologic values were compared be tween groups with the Student's t test. Infarct volumes were correlated with neurologic grades by the Spearman rank corre lation coefficient, whereas neurologic grades were compared between groups by the Mann-Whitney U statistic. Parametric values are expressed as mean ± standard deviation (SD). Sig nificance was assumed if P < 0.05.
RESULTS
Western blotting with antihuman apoE allowed detec tion of apoE in both transgenic strains (Fig. 1) Infarct volumes were smaller in the APOE3 group (cor tex: APOE3-437 = 18 ± 4 mm 3 ; APOE4-81 = 30 ± 11 mm 3 , P = 0.04; subcortex: APOE3-437 = 12 ± 4 mm 3 ;
APOE4-81 = 18 ± 4mm 3 , P = 0.003). Mean total in farct volume was 37.5% smaller in the APOE3-437 ver sus APOE4-81 mice (P = 0.02; Fig. 3 ). Correlation between neurologic score and infarct size was significant (P = 0.02).
There were no significant differences among experi mental groups for physiologic values (as determined in surrogate animals) ( rodents and primates/humans in histologic patterns of normal central nervous system apoE immunoreactivity.
In rodents, apoE is confined largely to astrocytes (Boyles et aI., 1985) , although small extracellular deposits have been described in the perivascular and periarachnoid spaces (Boyles et aI., 1985; Horsburgh and Nicoll, 1996a; Kida et aI., 1995) . There is no evidence of apoE immunoreactivity in rodent neurons other than that ob served in the postischemic state (Ali et aI., 1996; Hors burgh and Nicoll, 1996b) . In humans, apoE immunore activity normally is present in some neurons, as well as in astrocytes (Han et aI., 1994a,b) . Therefore, the pres ence of species-specific histologic expression of apoE J Cereb Blood Flow Metab, Vol. 18, No.4, 1998 within the central nervous system and the lack of homol ogy with the human gene complicates the use of wild type rodent models when attempting to understand the role of apoE in neurologic disease.
Recently, transgenic mice have been created that ex press human apoE3 or apoE4 isoforrns but lack endog enous murine apoE (Xu et aI., 1996) . Serum cholesterol is normal in these mice, suggesting the presence of func tional apoE protein. Moreover, these mice have been created to express apoE under the control of human pro moter sequences and tissue expression elements, The re sult is a "humanized" pattern of expression-that is, a pattern of neuronal and glial immunoreactivity is ob served. This experiment demonstrates that mice express ing the apoE4 isoform have significantly larger infarct volumes than those expressing the apoE3 isoforrn. Also, total infarct volume in the apoE4 animals (48 ± 14 mm 3 ) was larger that that previously observed in wild-type C57BLl6J mice (25 ±13 mm 3 ) exposed to an identical insult (Laskowitz et aI., 1997b) . The finding that apoE4
is associated with worse outcome from an acute central nervous system insult is consistent with clinical obser vations suggesting that the APOE genotype influences recovery from brain injury in an allele-specific fashion,
There are limitations of our model that warrant con sideration. First, it is likely that the human APOE3 and APOE4 genes were inserted at different sites in the mouse genome. The extent to which specific upstream regulatory elements interact with apoE expression in re sponse to injury is unknown, Second, Western blot analysis in this experiment has revealed that apoE pro duction was greater in the APOE4-81 mice relative to that in the APOE3-437 mice. Our previous work sug gested that murine apoE plays a protective role in re sponse to focal ischemia (Laskowitz et aI., 1997b) , Therefore, the most likely explanation for our findings is that the difference in infarct volume between these two lines is secondary to an isoform-specific effect and not a (Barone et aI., 1993; Schauwaecker and Steward, 1997) . The magnitude of such an effect in our study is not known.
It is unlikely that the increased infarct volumes ob served in the APOE4 transgenic mice were due to neu roanatomic differences between these two murine lines because no differences in the gross or histologic brain morphology have been observed in transgenic or apoE deficient mice at the ages used in this experiment (Masliah et aI., 1995; Xu et aI., 1996) . It also is unlikely that the observed differences in infarct volumes were due to microvascular disease, given the young age of the animals. No hemodynamically significant lesions have been observed, even in apoE-deficient mice within this age range, despite marked hypercholesterolemia (Plump et aI., 1992; Reddick et aI., 1994; Zhang et aI., 1992) .
Direct cerebral blood flow measurements will be re quired, however, to ensure that the volume of tissue at risk for infarction was similar between the APOE3 and APOE4 groups.
Although there is mounting evidence that apoE plays a role in acute and chronic neurologic disease, its func tion in injured brain remains poorly defined. There is preliminary evidence suggesting several potential mechanisms of action that are not necessarily mutually exclusive. One possible role of apoE is protection against oxidative insults and the ensuing process of lipid peroxi dation, as suggested by a recent report that apoE pro tected a neuronal cell line from hydrogen peroxide tox icity (Miyata and Smith, 1996) . This mechanism also is consistent with observations that plasma lipoproteins from apoE-deficient mice are more susceptible to in vitro oxidation than those of wild-type mice (Hayek et aI., 1994) . Further, apoE-deficient animals express higher titers of autoantibodies directed against oxidized lipid than control animals (Palin ski et aI., 1994). Presumably, apoE could act as a free radical scavenger, stabilizing lipid membranes against oxidative insult. Alternatively, apoE may sequester peroxidized lipids to prevent propa gation of lipid peroxidation. It also has been suggested that apoE plays a role in membrane remodeling as a lipid carrier after neuronal injury (Poirier et aI., 1991) .
Another mechanism by which apoE might ameliorate effects of focal ischemia is by down-regulation of the inflammatory response. Apolipoprotein E is known to have immunomodulatory properties in vitro, including suppression of lymphocyte proliferation and immuno globulin synthesis (Curtiss and Edgington, 1976; Pepe and Curtiss, 1986) . Apolipoprotein E might play a unique role in the brain, where it is the primary apoli poprotein produced. This is supported by recent experi ments in cell culture that demonstrate that apoE sup presses glial secretion of tumor necrosis factor-a (Laskowitz et aI., 1997a) . We also recently observed that apoE inhibits microglial synthesis of nitric oxide and inflammatory cytokines in an isoform-specific fashion (Laskowitz et. aI., in press ). Inflammation after ischemia may exacerbate brain injury by contributing to edema, blood-brain barrier breakdown, and release of reactive oxygen species by activated microglia.
A third possibility is that apoE exerts a neurotrophic effect on injured neurons. This is consistent with in vitro observations that apoE promotes survival and neurite outgrowth in an isoform-specific fashion (Bellosta et aI., 1995; Holzman et a!., 1995; Nathan et aI., 1994) . In addition to these direct neurotrophic effects, apoE has been demonstrated to bind to and potentiate the neuro trophic effects of ciliary neurotrophic factor (Gutman et aI., 1997) . Similarly, apoE binds to heparinized compo nents of the extracellular matrix, such as laminin, to en hance neuronal adhesion and growth (Huang et aI., 1995) .
Transgenic mice expressing the human apoE4 isoform have larger infarct volumes after 60 minutes of focal ischemia than human apoE3 transgenic mice. Apolipo protein E appears to play an isoforrn-specific role in the brain, modulating the effects of ischemia. This is con sistent with clinical observations that apoE plays an iso form-specific role in outcome after other forms of acute central nervous system insults, including intracranial hemorrhage, closed head injury, and stroke, and after cardiopulmonary bypass. The mechanisms by which apoE modulates the response to injury remain unclear, but transgenic models of human apoE expression prob ably will help to define brain metabolism of this multi functional protein.
